3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Neuroendocrine Tumors
2
Urogenital Neoplasms
1
Prostatic Diseases
1
Oligometastatic Prostate Cancer (OMPC)
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Advanced Gastroenteropancreatic Neuroendocrine Tumor
1
Interventions
Bevacizumab
56
Cetuximab
50
Fluorouracil
45
Leucovorin
39
Oxaliplatin
38
pembrolizumab
31
Specimen Handling
27
Irinotecan
25
Magnetic Resonance Spectroscopy
17
Biopsy
17
Nivolumab
15
HMPL-013
13
Folfox protocol
13
Capecitabine
13
Gemcitabine
12
Cisplatin
12
trifluridine tipiracil drug combination
11
Panitumumab
11
Carboplatin
11
Pemetrexed
9
IFL protocol
9
encorafenib
8
balstilimab
8
Standard of Care
8
Paclitaxel
8
Early Intervention, Educational
8
130-nm albumin-bound paclitaxel
8
fludarabine
7
atezolizumab
7
Educational Status
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Lutetium-177
×
90 days
×
Clear all
No trials found.